Literature DB >> 20083684

Failure of postnatal ductus arteriosus closure in prostaglandin transporter-deficient mice.

Hee-Yoon Chang1, Joseph Locker, Run Lu, Victor L Schuster.   

Abstract

BACKGROUND: Prostaglandin E(2) (PGE(2)) plays a major role both in maintaining patency of the fetal ductus arteriosus and in closure of the ductus arteriosus after birth. The rate-limiting step in PGE(2) signal termination is PGE(2) uptake by the transporter PGT. METHODS AND
RESULTS: To determine the role of PGT in ductus arteriosus closure, we used a gene-targeting strategy to produce mice in which PGT exon 1 was flanked by loxP sites. Successful targeting was obtained because neither mice hypomorphic at the PGT allele (PGT Neo/Neo) nor global PGT knockout mice (PGT(-/-)) exhibited PGT protein expression; moreover, embryonic fibroblasts isolated from targeted mice failed to exhibit carrier-mediated PGE(2) uptake. Although born in a normal mendelian ratio, no PGT(-/-) mice survived past postnatal day 1, and no PGT Neo/Neo mice survived past postnatal day 2. Necropsy revealed patent ductus arteriosus with normal intimal thickening but dilated cardiac chambers. Both PGT Neo/Neo and PGT(-/-) mice could be rescued through the postnatal period by giving the mother indomethacin before birth. Rescued mice grew normally and had no abnormalities by gross and microscopic postmortem analyses. In accordance with the known role of PGT in metabolizing PGE(2), rescued adult PGT(-/-) mice had lower plasma PGE(2) metabolite levels and higher urinary PGE(2) excretion rates than wild-type mice.
CONCLUSIONS: PGT plays a critical role in closure of the ductus arteriosus after birth by ensuring a reduction in local and/or circulating PGE(2) concentrations.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20083684      PMCID: PMC2836805          DOI: 10.1161/CIRCULATIONAHA.109.862946

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  43 in total

1.  KLF2 provokes a gene expression pattern that establishes functional quiescent differentiation of the endothelium.

Authors:  Rob J Dekker; Reinier A Boon; Mariska G Rondaij; Astrid Kragt; Oscar L Volger; Yvonne W Elderkamp; Joost C M Meijers; Jan Voorberg; Hans Pannekoek; Anton J G Horrevoets
Journal:  Blood       Date:  2006-02-02       Impact factor: 22.113

Review 2.  Patent ductus arteriosus.

Authors:  Douglas J Schneider; John W Moore
Journal:  Circulation       Date:  2006-10-24       Impact factor: 29.690

Review 3.  Prostaglandins in health and disease: an overview.

Authors:  Stephen B Miller
Journal:  Semin Arthritis Rheum       Date:  2006-07-03       Impact factor: 5.532

4.  Coordinate control of prostaglandin E2 synthesis and uptake by hyperosmolarity in renal medullary interstitial cells.

Authors:  Michael L Pucci; Shinichi Endo; Teruhisa Nomura; Run Lu; Cho Khine; Brenda S Chan; Yi Bao; Victor L Schuster
Journal:  Am J Physiol Renal Physiol       Date:  2005-11-01

5.  Cloning of mouse prostaglandin transporter PGT cDNA: species-specific substrate affinities.

Authors:  M L Pucci; Y Bao; B Chan; S Itoh; R Lu; N G Copeland; D J Gilbert; N A Jenkins; V L Schuster
Journal:  Am J Physiol       Date:  1999-09

6.  Chronic activation of the prostaglandin receptor EP4 promotes hyaluronan-mediated neointimal formation in the ductus arteriosus.

Authors:  Utako Yokoyama; Susumu Minamisawa; Hong Quan; Shibnath Ghatak; Toru Akaike; Eri Segi-Nishida; Shiho Iwasaki; Mari Iwamoto; Suniti Misra; Kouichi Tamura; Hideaki Hori; Shumpei Yokota; Bryan P Toole; Yukihiko Sugimoto; Yoshihiro Ishikawa
Journal:  J Clin Invest       Date:  2006-11       Impact factor: 14.808

7.  The paradoxical patent ductus arteriosus.

Authors:  Kathryn N Ivey; Deepak Srivastava
Journal:  J Clin Invest       Date:  2006-11       Impact factor: 14.808

8.  Indomethacin promotes nitric oxide function in the ductus arteriosus in the mouse.

Authors:  D Sodini; B Baragatti; S Barogi; V E Laubach; F Coceani
Journal:  Br J Pharmacol       Date:  2008-02-25       Impact factor: 8.739

9.  Prostaglandin E2-activated Epac promotes neointimal formation of the rat ductus arteriosus by a process distinct from that of cAMP-dependent protein kinase A.

Authors:  Utako Yokoyama; Susumu Minamisawa; Hong Quan; Toru Akaike; Sayaka Suzuki; Meihua Jin; Qibin Jiao; Mayumi Watanabe; Koji Otsu; Shiho Iwasaki; Shigeru Nishimaki; Motohiko Sato; Yoshihiro Ishikawa
Journal:  J Biol Chem       Date:  2008-08-11       Impact factor: 5.157

10.  Human prostaglandin transporter gene (hPGT) is regulated by fluid mechanical stimuli in cultured endothelial cells and expressed in vascular endothelium in vivo.

Authors:  J N Topper; J Cai; G Stavrakis; K R Anderson; E A Woolf; B A Sampson; F J Schoen; D Falb; M A Gimbrone
Journal:  Circulation       Date:  1998-12-01       Impact factor: 29.690

View more
  29 in total

Review 1.  Diabetes-induced birth defects: what do we know? What can we do?

Authors:  E Albert Reece
Journal:  Curr Diab Rep       Date:  2012-02       Impact factor: 4.810

2.  A link between smooth muscle cell death and extracellular matrix degradation during vascular atrophy.

Authors:  Richard D Kenagy; Seung-Kee Min; Eileen Mulvihill; Alexander W Clowes
Journal:  J Vasc Surg       Date:  2011-04-14       Impact factor: 4.268

Review 3.  Roles of Organic Anion Transporting Polypeptide 2A1 (OATP2A1/SLCO2A1) in Regulating the Pathophysiological Actions of Prostaglandins.

Authors:  Takeo Nakanishi; Ikumi Tamai
Journal:  AAPS J       Date:  2017-12-04       Impact factor: 4.009

Review 4.  Genetics of the patent ductus arteriosus (PDA) and pharmacogenetics of PDA treatment.

Authors:  Tamorah R Lewis; Elaine L Shelton; Sara L Van Driest; Prince J Kannankeril; Jeff Reese
Journal:  Semin Fetal Neonatal Med       Date:  2018-02-24       Impact factor: 3.926

5.  PGE2 through the EP4 receptor controls smooth muscle gene expression patterns in the ductus arteriosus critical for remodeling at birth.

Authors:  Artiom Gruzdev; MyTrang Nguyen; Martina Kovarova; Beverly H Koller
Journal:  Prostaglandins Other Lipid Mediat       Date:  2012-02-11       Impact factor: 3.072

6.  Unraveling the transcriptional determinants of liver sinusoidal endothelial cell specialization.

Authors:  Willeke de Haan; Cristina Øie; Mohammed Benkheil; Wouter Dheedene; Stefan Vinckier; Giulia Coppiello; Xabier López Aranguren; Manu Beerens; Joris Jaekers; Baki Topal; Catherine Verfaillie; Bård Smedsrød; Aernout Luttun
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2020-03-02       Impact factor: 4.052

7.  Exome sequencing identifies SLCO2A1 mutations as a cause of primary hypertrophic osteoarthropathy.

Authors:  Zhenlin Zhang; Weibo Xia; Jinwei He; Zeng Zhang; Yaohua Ke; Hua Yue; Chun Wang; Hao Zhang; Jiemei Gu; Weiwei Hu; Wenzhen Fu; Yunqiu Hu; Miao Li; Yujuan Liu
Journal:  Am J Hum Genet       Date:  2011-12-22       Impact factor: 11.025

8.  The organic anion transporter SLCO2A1 constitutes the core component of the Maxi-Cl channel.

Authors:  Ravshan Z Sabirov; Petr G Merzlyak; Toshiaki Okada; Md Rafiqul Islam; Hiromi Uramoto; Tomoko Mori; Yumiko Makino; Hiroshi Matsuura; Yu Xie; Yasunobu Okada
Journal:  EMBO J       Date:  2017-10-18       Impact factor: 11.598

Review 9.  Primary hypertrophic osteoarthropathy: an update.

Authors:  Zeng Zhang; Changqing Zhang; Zhenlin Zhang
Journal:  Front Med       Date:  2013-01-23       Impact factor: 4.592

Review 10.  The Prostaglandin Transporter: Eicosanoid Reuptake, Control of Signaling, and Development of High-Affinity Inhibitors as Drug Candidates.

Authors:  Victor L Schuster; Yuling Chi; Run Lu
Journal:  Trans Am Clin Climatol Assoc       Date:  2015
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.